These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18247452)

  • 1. Molecular and serological diagnosis of Borrelia burgdorferi infection among patients with diagnosed Erythema migrans.
    Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Rymaszewska A; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
    Ann Agric Environ Med; 2007; 14(2):209-13. PubMed ID: 18247452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy.
    Schmidt B; Muellegger RR; Stockenhuber C; Soyer HP; Hoedl S; Luger A; Kerl H
    J Clin Microbiol; 1996 Jun; 34(6):1359-63. PubMed ID: 8735081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in urine specimens of patients with erythema migrans lesions.
    Mercier G; Burckel A; Lucotte G
    Mol Cell Probes; 1997 Apr; 11(2):89-94. PubMed ID: 9160322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis.
    Chmielewska-Badora J; Cisak E; Wójcik-Fatla A; Zwoliński J; Buczek A; Dutkiewicz J
    Ann Agric Environ Med; 2006; 13(2):307-11. PubMed ID: 17196006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment.
    Muellegger RR; Zoechling N; Soyer HP; Hoedl S; Wienecke R; Volkenandt M; Kerl H
    Arch Dermatol; 1995 Jun; 131(6):678-82. PubMed ID: 7778919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis.
    Lebech AM; Hansen K; Brandrup F; Clemmensen O; Halkier-Sørensen L
    Mol Diagn; 2000 Jun; 5(2):139-50. PubMed ID: 11066015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of 10 cases of Lyme disease presenting with erythema migrans in Istanbul, Turkey].
    Akın Belli A; Derviş E; Özbaş Gök S; Midilli K; Gargılı A
    Mikrobiyol Bul; 2015 Oct; 49(4):525-31. PubMed ID: 26649410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
    Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
    Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis.
    Hammers-Berggren S; Lebech AM; Karlsson M; Svenungsson B; Hansen K; Stiernstedt G
    J Clin Microbiol; 1994 Jun; 32(6):1519-25. PubMed ID: 8077398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
    Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
    Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical forms of neuroborreliosis among hospitalized patients in the years 2000-2005].
    Czupryna P; Kuśmierczyk J; Zajkowska JM; Ciemerych M; Kondrusik M; Ciemerych A; Pancewicz SA
    Pol Merkur Lekarski; 2007 Aug; 23(134):103-6. PubMed ID: 18044338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course of Borrelia burgdorferi DNA shedding in urine after treatment.
    Aberer E; Bergmann AR; Derler AM; Schmidt B
    Acta Derm Venereol; 2007; 87(1):39-42. PubMed ID: 17225014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.
    Smith RP; Schoen RT; Rahn DW; Sikand VK; Nowakowski J; Parenti DL; Holman MS; Persing DH; Steere AC
    Ann Intern Med; 2002 Mar; 136(6):421-8. PubMed ID: 11900494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary erythema migrans in Georgia and South Carolina.
    Felz MW; Chandler FW; Oliver JH; Rahn DW; Schriefer ME
    Arch Dermatol; 1999 Nov; 135(11):1317-26. PubMed ID: 10566829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis.
    Marangoni A; Moroni A; Accardo S; Cevenini R
    Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):349-54. PubMed ID: 18197445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
    Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
    Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.